Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Álvarez, Luis Miguel Garcia Sousa, Paz Casas et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 22
Clinical experience with integrase inhibitors in HIV-2-infected individuals in SpainSilvia Requena, Carmen Raya, Carmen Rodríguez et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 20
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendationsCarlos Enrique Guerrero-Beltrán, Javier Martínez‐Sanz, Marta Álvarez et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 16
Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in SpainCarmen de Mendoza, Emilio Pérez‐Trallero, María Pirón et al.|Open Forum Infectious Diseases|2019Cited by 9
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021Laura Viñuela, Féderico García, Adolfo de Salazar et al.|Journal of Medical Virology|2023Cited by 7